Alzheimer’s and Dementia: Practical Application of Blood Biomarkers in the Primary Care Setting

Symptoms of dementia can be complex. We recently hosted a webinar on how advancements in testing of blood-based biomarkers (BBMs) can provide clarity and inform the appropriate triaging of patients suspected of Alzheimer’s disease (AD).

What can you expect from this webinar?

In this webinar, you’ll learn about:

• Prevalence of different types of dementia
• The evolving standard of care and diagnostics for AD
• Performance standards for confirmatory and triage blood tests and recommended use in practice
• Detailed overview of BBMs including pTau-217, the ATN Profile and the FDA-cleared Lumipulse® pTau-217/Beta Amyloid 42 Ratio